N
HLVX

Nuveen’s HilleVax HLVX Stock Holding History

Nuveen’s Portfolio HLVX Stock Details HLVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-137,713
Closed -$1.99M – 3342
2024
Q2 		$1.99M Buy
137,713
+89,303
+184% +$1.23M ﹤0.01% 2399
2024
Q1 		$805K Hold
48,410
– – ﹤0.01% 2785
2023
Q4 		$777K Buy
48,410
+8,798
+22% +$117K ﹤0.01% 2839
2023
Q3 		$533K Sell
39,612
-356
-0.9% -$5.01K ﹤0.01% 2826
2023
Q2 		$687K Buy
39,968
+16,066
+67% +$249K ﹤0.01% 2825
2023
Q1 		$395K Hold
23,902
– – ﹤0.01% 2862
2022
Q4 		$400K Buy
23,902
+5,533
+30% +$99.9K ﹤0.01% 2936
2022
Q3 		$314K Hold
18,369
– – ﹤0.01% 3039
2022
Q2 		$201K Buy
+18,369
New +$218K ﹤0.01% 3150

Other funds holding HLVX

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Nuveen's HLVX Position: Q3 2024 in Review

Nuveen sold out of HilleVax (HLVX) in Q3 2024, closing a stake of 137,713 shares — an estimated $1.99M sold.

Nuveen first reported a position in HLVX in Q2 2022 and held it in 9 quarters. The position peaked at $1.99M in Q2 2024. 79 funds tracked by Wall St. Rank hold HLVX as of Q3 2024.

  • Nuveen reported no remaining HilleVax position as of Q3 2024 after selling out during the quarter.
  • Nuveen sold 137,713 HilleVax shares in Q3 2024, an estimated $1.99M.
  • Nuveen first reported a position in HilleVax in Q2 2022 and held it in 9 quarters.
  • Nuveen's HilleVax position peaked at $1.99M in Q2 2024.
  • 79 funds tracked by Wall St. Rank held HilleVax as of Q3 2024.

Based on Nuveen's 13F filing for Q3 2024, filed 14 Nov 2024.